世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034645

高リン血症治療の世界市場レポート(2023年)

The Business Research Company

Hyperphosphatemia Treatment Global Market Report 2023

発刊日 2023/03/03

言語英語

体裁PDF、Word、Excel データ ダッシュボード/200ページ

ライセンス/価格200ページ

0000034645

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界の高リン血症治療市場を評価するために必要な重要な情報を提供します。

本レポートは、力強い成長を経験している高リン血症治療市場に焦点を当てています。本 レポートは、今後10年以上にわたって私たちの生活を形作り変化させる高リン血症治療市場へのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 製品別
    ➣ セベラマー
    ➣ カルシウムベースのリン酸塩結合剤
    ➣ 鉄ベースのリン酸バインダー
    ➣ 炭酸ランタン
    ➣ その他の製品
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンラインストア
  • 調査企業
    ➣ Sanofi
    ➣ 武田製薬工業(Takeda Pharmaceutical Company Limited)
    ➣ Astellas Pharma Inc
    ➣ Akebia Therapeutics, Inc.
    ➣ Vifor Pharma Management Ltd.
  • 調査国
    ➣ オーストラリア
    ➣ ブラジル
    ➣ 中国
    ➣ フランス
    ➣ ドイツ
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ ロシア
    ➣ 韓国
    ➣ イギリス
    ➣ アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形式
    ➣ PDF
    ➣ Word
    ➣ Excel データダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Hyperphosphatemia Treatment Market Characteristics

3. Hyperphosphatemia Treatment Market Trends And Strategies

4. Hyperphosphatemia Treatment Market - Macro Economic Scenario
4.1 COVID-19 Impact On Hyperphosphatemia Treatment Market
4.2 Ukraine-Russia War Impact On Hyperphosphatemia Treatment Market
4.3 Impact Of High Inflation On Hyperphosphatemia Treatment Market

5. Hyperphosphatemia Treatment Market Size And Growth
5.1. Global Hyperphosphatemia Treatment Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Hyperphosphatemia Treatment Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Hyperphosphatemia Treatment Market Segmentation
6.1. Global Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Sevelamer
Calcium-Based Phosphate Binders
Iron-Based Phosphate Binders
Lanthanum Carbonate
Other products
6.2. Global Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital pharmacy
Retail Pharmacy
Online stores

7. Hyperphosphatemia Treatment Market Regional And Country Analysis
7.1. Global Hyperphosphatemia Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Hyperphosphatemia Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Hyperphosphatemia Treatment Market
8.1. Asia-Pacific Hyperphosphatemia Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Hyperphosphatemia Treatment Market
9.1. China Hyperphosphatemia Treatment Market Overview
9.2. China Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Hyperphosphatemia Treatment Market
10.1. India Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Hyperphosphatemia Treatment Market
11.1. Japan Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Hyperphosphatemia Treatment Market
12.1. Australia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Hyperphosphatemia Treatment Market
13.1. Indonesia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Hyperphosphatemia Treatment Market
14.1. South Korea Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Hyperphosphatemia Treatment Market
15.1. Western Europe Hyperphosphatemia Treatment Market Overview
15.2. Western Europe Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Hyperphosphatemia Treatment Market
16.1. UK Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Hyperphosphatemia Treatment Market
17.1. Germany Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Hyperphosphatemia Treatment Market
18.1. France Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Hyperphosphatemia Treatment Market
19.1. Eastern Europe Hyperphosphatemia Treatment Market Overview
19.2. Eastern Europe Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Hyperphosphatemia Treatment Market
20.1. Russia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Hyperphosphatemia Treatment Market
21.1. North America Hyperphosphatemia Treatment Market Overview
21.2. North America Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Hyperphosphatemia Treatment Market
22.1. USA Hyperphosphatemia Treatment Market Overview
22.2. USA Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Hyperphosphatemia Treatment Market
23.1. South America Hyperphosphatemia Treatment Market Overview
23.2. South America Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Hyperphosphatemia Treatment Market
24.1. Brazil Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Hyperphosphatemia Treatment Market
25.1. Middle East Hyperphosphatemia Treatment Market Overview
25.2. Middle East Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Hyperphosphatemia Treatment Market
26.1. Africa Hyperphosphatemia Treatment Market Overview
26.2. Africa Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Hyperphosphatemia Treatment Market Competitive Landscape And Company Profiles
27.1. Hyperphosphatemia Treatment Market Competitive Landscape
27.2. Hyperphosphatemia Treatment Market Company Profiles
27.2.1. Sanofi
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Takeda Pharmaceutical Company Limited
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Astellas Pharma Inc
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Akebia Therapeutics, Inc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Vifor Pharma Management Ltd.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Hyperphosphatemia Treatment Market

29. Hyperphosphatemia Treatment Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer

この商品のレポートナンバー

0000034645

TOP